Pharmaceutical - Pharmaceutical, Almirall

Filter

Current filters:

PharmaceuticalAlmirall

Popular Filters

1 to 25 of 56 results

Spanish pharma companies plan to continue extending their footprint around the world

03-06-2014

Spanish pharmaceutical companies have developed a strong strategy in the last years to expand their products…

AlmirallCinfaEsteve GroupFerrer InternacionalGlobalGrifolsKern PharmaMarkets & MarketingPharmaceuticalPharmaMarSpain

Almirall posts strong 1st-qtr 2014 results

Almirall posts strong 1st-qtr 2014 results

12-05-2014

Spain’s largest pharmaceutical company Almirall this morning reported first-quarter 2014 financial…

AlmirallFinancialPharmaceutical

Forest and Almirall get FDA feedback on fixed dose combo of aclidinium and formoterol

Forest and Almirall get FDA feedback on fixed dose combo of aclidinium and formoterol

09-04-2014

US drugmaker Forest Laboratories and partner Almirall, Spain’s largest pharma company, say they have…

aclidiniumAlmirallForest LaboratoriesformoterolNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryUSA

Almirall gains European rights to InDex Pharma’s Kappaproct

07-04-2014

Sweden’s InDex Pharmaceuticals and Spain’s largest drugmaker Almirall have signed a license agreement…

AlmirallEuropeGastro-intestinalsInDex PharmaceuticalsKappaproctLicensingPharmaceutical

Aqua’s acquisition to push Almirall in US dermatology market

03-04-2014

Spain’s largest drugmaker, Almirall (ALM: MC), announced at the end of last year the acquisition of…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Spanish pharma companies return to sales growth in 2013, after dismal 2012

Spanish pharma companies return to sales growth in 2013, after dismal 2012

04-03-2014

Spanish pharmaceutical companies, reporting their 2013 financial results, have started to see light at…

AlmirallEuropeFaes FarmaFinancialGrifolsPharmaceuticalZeltia

Almirall to acquire US dermatology firm for $305 million upfront

Almirall to acquire US dermatology firm for $305 million upfront

17-12-2013

Spain’s largest drugmaker, Almirall says it has reached a definitive agreement to acquire Aqua Pharmaceuticals,…

AlmirallAqua PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceutical

Almirall take steps, including cut job, to counter market problems in Europe

05-12-2013

Spain's largest drugmaker Almirall today revealed a reorganization at European level in order to optimize…

AlmirallManagementPharmaceutical

Sativex approved for MS in Switzerland

Sativex approved for MS in Switzerland

27-11-2013

UK-based GW Pharmaceuticals (AIM: GWP), which is focused on novel cannaboid therapeutics, has received…

AlmirallCNS DiseasesEuropeGW PharmaceuticalsPharmaceuticalRegulationSativex

Almirall’s third quarter results boosted by aclidinium sales

Almirall’s third quarter results boosted by aclidinium sales

11-11-2013

Spain's largest drugmaker Almirall (ALM: MC) has released third quarter 2013 financial results reporting…

aclidiniumAlmirallConstellaEuropeFinancialOncologyPharmaceuticalSativex

Aclidinium and formoterol fixed dose combo for COPD filed in Europe by Almirall

04-11-2013

Spain’s largest drugmaker Almirall has filed a Marketing Authorization Application to the European…

aclidiniumAlmirallEuropeformoterolPharmaceuticalRegulationRespiratory and Pulmonary

Agreement reached for Sativex pricing in Germany

25-09-2013

A German unit of Spain’s largest drugmaker Almirall, Hermal GmbH and Germany’s National Association…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

Almirall sets up new affiliate to support Canadian product launches

06-09-2013

Spain's largest pharma company, Almirall (ALM: MC) has continued its expansion with the launch of a new…

AlmirallManagementMarkets & MarketingNorth AmericaPharmaceuticalTudorza Genuair

Forest Labs and Almirall opt to delay US filing for combo COPD drug

15-08-2013

USA-based Forest Laboratories (NYSE: FRX) and Spain's largest drugmaker Almirall (ALM:MC) said late yesterday…

aclidiniumAlmirallForest LaboratoriesformoterolNorth AmericaPharmaceuticalRegulationRespiratory and PulmonaryTudorza Pressair

IQWiG finds no added benefit proven for Constella in IBS

07-08-2013

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

AlmirallConstellaEuropeGastro-intestinalsIronwood PharmaceuticalsPharmaceuticalPricingRegulation

Almirall first-half sales and earnings decline

29-07-2013

Spain's largest drugmaker Almirall (ALM: MC) reported first-half 2013 results, showing that net revenues…

AlmirallFinancialPharmaceutical

First approved new class of IBS-C therapy, Constella, now available in Europe

13-06-2013

Spain's largest drugmaker Almirall (ALM: MC) and US partner Ironwood Pharmaceuticals, (Nasdaq: IRWD)…

AlmirallConstellaEuropeGastro-intestinalsIronwood PharmaceuticalsMarkets & MarketingPharmaceuticalRegulation

Almirall pays GW Pharma milestone on Sativex; reports 1st-qtr results

07-05-2013

UK-based GW Pharmaceuticals (AIM: GWP) says that it has received commercialization approval for its cannabinoid-based…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Mixed results for Almirall and Forest's LAMA/LABA combo for COPD

02-05-2013

Spain's largest drugmaker Almirall (ALM: MC) and US partner Forest Laboratories (NYSE: FRX) have announced…

aclidiniumAlmirallForest LaboratoriesformoterolPharmaceuticalResearchRespiratory and Pulmonary

Positive Ph III results for Almirall and Forest's combination COPD drug

16-04-2013

Spain's largest pharma company Almirall (ALM: MC) and USA-based partner Forest Laboratories (NYSE:FRX)…

AlmirallBretaris GenuairEklira GenuairForest LaboratoriesPharmaceuticalResearchRespiratory and Pulmonary

Almirall could pull Sativex from German market due to inadequate pricing

20-03-2013

Almirall (ALM: MC), Spain's largest pharma company and the licensee for UK-based GW Pharmaceuticals'…

AlmirallEuropeGW PharmaceuticalsNeurologicalPharmaceuticalPricingSativex

The solution for Spanish pharma companies lies abroad

13-03-2013

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain…

AlmirallEuropeFinancialGrifolsPharmaceuticalPricingRegulationZeltia

Added benefit of Almirall's aclidinium bromide is not proven, says Germany's IQWiG

10-01-2013

The drug aclidinium bromide, trade names Eklira, Bretaris from Spain's largest drugmaker Almirall (ALM:…

aclidiniumAlmirallBretaris GenuairEkliraEuropePharmaceuticalPricingRegulationRespiratory and Pulmonary

1 to 25 of 56 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top